Replimune
REPL
#6484
Rank
NZ$1.20 B
Marketcap
NZ$14.59
Share price
6.94%
Change (1 day)
-25.20%
Change (1 year)

Market capitalization of Replimune (REPL)

Market cap: NZ$1.20 Billion

As of March 2026 Replimune has a market cap of NZ$1.20 Billion. This makes Replimune the world's 6484th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Replimune from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$1.20 B-10.69%
2025NZ$1.34 B-19.36%
2024NZ$1.67 B112.5%
2023NZ$0.78 B-63.05%
2022NZ$2.13 B14.53%
2021NZ$1.86 B-23.44%
2020NZ$2.43 B211.23%
2019NZ$0.78 B65.53%
2018NZ$0.47 B

End of Day market cap according to different sources

On Mar 8th, 2026 the market cap of Replimune was reported to be:

NZ$1.12 Billion
by Nasdaq info icon info icon
NZ$1.12 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ$2.18 B 81.23%๐Ÿ‡บ๐Ÿ‡ธ USA